The N-methyl-D-aspartate (NMDA) subtype of ionotropic glutamate receptors plays a Jekyll and Hyde role in the mammalian central nervous system. In pathological scenarios such as ischemia, Ca 2+ influx through the NMDA receptor is a key mediator of cell death. However, physiological levels of NMDA-receptor activity can promote neuronal survival and resistance to trauma and play important roles in synaptic plasticity and transmission. This dichotomy may explain the poor tolerance and efficacy of NMDA-receptor antagonists in clinical trials for excitotoxic trauma. There is a growing understanding of the signaling events that mediate the opposing effects of NMDA-receptor activity and the factors that determine whether an episode of NMDA-receptor activity will promote survival or death. This knowledge may lead to therapeutic strategies that enable the selective blockade of prodeath signaling cassettes while sparing physiological signaling to survival and plasticity. NEUROSCIENTIST 13 (6): 572-579, 2007. 
N-methyl-D-aspartate receptors (NMDARs) are cationotropic receptors gated by the neurotransmitter glutamate. They play a central role in synaptic transmission and in mediating synaptic plasticity, learning, and memory. NMDARs are also present in other cell types such as oligodendrocytes (Karadottir and others 2005) , osteoclasts (Szczesniak and others 2005) , and lymphocytes (Tuneva and others 2003) , in which their function is not well understood. Structurally, they are heterotetramers, typically containing two glycine-binding NR1 subunits and two glutamate-binding NR2 subunits. The NR1 subunit is essential for a functional NMDAR and has several splice variants that can influence the properties of the channel. In addition, NMDAR variety is provided by the four different NR2 subunits (NR2A-D) as well as two NR3 genes (NR3A and NR3B), which can take the place of NR2. The most widely expressed NMDARs contain the obligate subunit NR1 plus either NR2B or NR2A or a mixture of the two. NR2B (and NR2D) is expressed at high levels in early developmental stages that decline postnatally, whereas expression levels of NR2A and NR2C increase (Kohr 2006) . In adults, NR2A is ubiquitously expressed in the brain, NR2B is mostly restricted to the forebrain, NR2C is mostly restricted to the cerebellum, and NR2D is expressed in small numbers of cells in selected brain regions. However, NR2A and NR2B exist concurrently in the same brain region and participate in the formation of heterotrimeric NR1, NR2A, and NR2B functional NMDARs (Waxman and Lynch 2005) .
The NMDAR channel pore is blocked in a voltagedependent manner by Mg 2+ . Release of glutamate, the main excitatory neurotransmitter in the mammalian CNS, causes Na + influx through AMPA receptors in the postsynaptic cell, resulting in partial membrane depolarization sufficient to lift the Mg 2+ block. The activated NMDAR is permeable to Na + , but crucially, also to Ca 2+ . This Ca 2+ mediates most of the physiological effects of NMDAR activity.
At the synapse, the NMDAR is linked to a large, multiprotein complex via the cytoplasmic C-termini of NR1 and NR2 subunits (Collins and others 2006) . This complex facilitates localization of the receptor in specific areas such as the postsynaptic density (PSD) and facilitates connection to a variety of downstream signaling molecules through which many NMDAR-activity downstream effects are mediated (Waxman and Lynch 2005) . The extreme Ctermini of NR2 subunits link to a group of proteins called membrane-associated guanylate kinases (MAGUKs), which include PSD-95, SAP-102 (synapse-associated protein), and PSD-93. These proteins contain several PDZprotein interaction domains through which other proteins are connected. This highly organized structure facilitates signal coupling by bringing together cytoplasmic signaltransducing enzymes and cell-surface receptors. Moreover, it can bring Ca 2+ -dependent signaling molecules into close proximity with the site of Ca 2+ entry at NMDARs. For example, neuronal nitric oxide synthase (nNOS), in interacting with PSD-95, is brought close to the NMDAR and can thus be efficiently activated by NMDAR-mediated Ca 2+ influx (Aarts and others 2002) .
NMDARs are essential mediators of synaptic plasticity and also mediate aspects of development and synaptic transmission (Aamodt and Constantine-Paton 1999; Bliss and Collingridge 1993) . However, when excessively activated, NMDARs cause cell death in many neuropathological scenarios (Lipton and Rosenberg 1994) . During an ischemic episode, extracellular glutamate builds up as a result of synaptic release and impaired or reversed uptake mechanisms (Camacho and Massieu 2006; Rossi and others 2000) , resulting in overactivation of NMDARs (Choi 1988) . The destructive effects of excessive NMDAR activity are in contrast to the recent findings that survival of several neuronal types depends on physiological synaptic NMDAR activity (Hardingham and Bading 2003; Ikonomidou and Turski 2002) . Thus, responses of neurons to glutamate or NMDA follow a bellshaped curve: both too much and too little NMDAR activity are potentially harmful (Lipton and Nakanishi 1999) .
Failed Clinical Trials for Stroke With NMDA-Receptor Antagonists
Despite an overwhelming body of evidence from animal studies that implicates NMDAR activity in neuronal loss following ischemia, the many clinical trials of different NMDAR antagonists for stroke have failed because of poor tolerance and efficacy (Ikonomidou and Turski 2002; Muir 2006) . Aptiganel, one of the final-generation antagonists, is a case in point. Clinical trials were suspended because of lack of efficacy and emerging data that patients taking high-dose Aptiganel exhibited less neurological improvement and higher mortality than did those taking a placebo (Albers and others 2001) . Lack of efficacy was observed despite using dosages that caused side effects such as hypertension as well as CNS-adverse events such as sedation, confusion, headache, and psychosis (Dyker and others 1999) . The important role of the NMDAR in normal CNS functioning may mean that for any antagonist, the maximal tolerated dosage is lower than the minimum therapeutically effective dosage. Moreover, the growing body of evidence that physiological synaptic NMDAR activity exerts a neuroprotective effect has led to suggestions that it may play a role in promoting recovery and preventing delayed neuronal loss in the penumbra (Albers and others 2001; Ikonomidou and Turski 2002) . Indeed, preconditioning-type events are likely to be initiated in the marginal area in the penumbra, and because preconditioning is NMDAR dependent (Grabb and Choi 1999) , blockade may be undesirable in this region. Thus, global NMDAR antagonists may block NMDAR-activated prosurvival signals triggered in response to an ischemic challenge and actually delay recovery in some areas. This dichotomy of NMDAR signaling (Hardingham and Bading 2003) means that any antiexcitotoxic strategy that interferes with NMDAR signaling should be assessed to determine its effects on NMDAR prosurvival signaling. This will require a thorough understanding of the nature of both the survival and the death pathways triggered by the NMDAR. In this review, we will focus on survival and death signaling through the NMDA receptor, exploring newly emerged concepts and the molecules involved.
Prosurvival Signaling From the NMDAR
In contrast to the adverse effects of excessive NMDAR activity, physiological levels of synaptic NMDAR activity are essential for neuronal survival, because activity blockade was shown to have deleterious effects. Blockade of NMDAR activity in vivo caused a decrease in the number of healthy cells, increased density of pyknotic cells, and severe deterioration of the dentate-gyrus morphology in first-week-postnatal rat pups (Gould and others 1994) . Elimination of NMDA-receptor activity in vivo causes widespread apoptosis and enhances trauma-induced injury in developing neurons (Adams and others 2004; Gould and others 1994; Ikonomidou and others 1999; Monti and Contestabile 2000; Pohl and others 1999) . In the adult CNS, NMDAR blockade exacerbates neuronal loss when applied after traumatic brain injury and during ongoing neurodegeneration (Ikonomidou and others 2000) and prevents the survival of newborn neurons in the adult dentate gyrus (Tashiro and others 2006) . NMDAR signaling to survival has been recapitulated in vitro in neuronal cultures (Hardingham and Bading 2003; Hetman and Kharebava 2006) , allowing scientists to study the underlying signaling events. Network disinhibition using the GABA a -receptor antagonist bicuculline enabled selective studies of synaptic NMDAR-activity signaling (Hardingham and others 2001b) , as opposed to using the unphysiological bath application of glutamate, which would activate synaptic and extrasynaptic NMDARs. Bicuculline blockade of the tonic inhibition mediated by GABAergic interneurons promotes action-potential bursting that is associated with synaptic NMDAR-dependent Ca 2+ transients (Hardingham and others 2002) .
Prosurvival signaling from the NMDA receptor can involve posttranslational modifications of proteins, or indeed, de novo gene expression. Different signals may have varying importance under different circumstances (Papadia and others 2005) . Below, we outline examples of prosurvival pathways triggered by synaptic NMDAR activity (see also Fig. 1 ) and the prosurvival events that they mediate. Prosurvival and prodeath signaling from the NMDA receptor (see text for details). Note that prodeath signaling generally requires more intense activation of NMDARs than does prosurvival signaling. Also, the pathways marked with * are favored by extrasynaptic NMDAR activation (Hardingham and others 2002; Ivanov and others 2006) . Ψm = mitochondrial membrane potential.
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NMDA Receptor Signaling
The PI3K-Akt Pathway
The PI3K (phosphoinositide-3-kinase)-Akt kinase cascade is a key signaling pathway responsible for prosurvival effects of NMDAR activity (Lafon-Cazal and others 2002; Papadia and others 2005) . It is strongly activated by NMDAR in many neuronal types (Hetman and Kharebava 2006) . Briefly, in response to extracellular stimuli, PI3K, which can be activated in a Ca 2+ -dependent manner by Ca 2+ / calmodulin (Joyal and others 1997) , catalyzes the phosphorylation of the lipid phosphatidylinositol 4,5-biphosphate (PIP2) to phosphatidylinositol 3,4,5-triphosphate (PIP3) in the membrane. The kinase PDK1 (phosphoinositidedependent protein kinase; Alessi and others 1997) as well as its substrate Akt/PKB (protein kinase B) are recruited to the membrane via their interactions with PIP3 through their pleckstrin homology (PH) domains. PDK1, along with PDK2 (which is possibly rictor-mTOR; Sarbassov and others 2005), then phosphorylates and activates Akt. Akt promotes cell survival and growth via phosphorylation and activation or inactivation of its many targets Akt phosphorylates and inactivates glycogen synthase kinase-3 beta (GSK3β; Cross and others 1995), an event that also contributes to NMDAR signaling to neuroprotection (Soriano and others 2006) . In the context of neurotrophic-factor and growth-factor signaling, Akt triggers phosphorylation of the forkhead box O (FOXO) subfamily of forkhead transcription factors, promoting translocation from the nucleus to the cytoplasm (Brunet and others 1999) . FOXOs control the expression of prodeath genes such as Fas ligand (Brunet and others 1999) and Bim (Gilley and others 2003) , and these are down-regulated by Akt activation. NMDAR signaling to Akt-dependent FOXO export has also been observed in the context of NMDAR signaling (Soriano and others 2006) . Akt also inactivates the proapoptotic Bcl-2 family member BAD (Bc12/Bcl-X L -antagonist causing cell death) by phosphorylation, thus stopping its interaction with and blockade of the pro-survival Bcl-2 family members Bcl-2 and Bcl-X L (Downward 1999) . The c-Jun N-terminal kinase (JNK)/p38 activator ASK1 can also be inhibited by Akt phosphorylation (Kim and others 2001) , and p53 transcriptional activity is suppressed by Akt, leading to reduction of Bax expression and of neuronal death (Yamaguchi and others 2001) .
CREB (cAMP-Response-Element-Binding Protein)
A key mediator of activity-dependent gene expression is the transcription factor CREB, which binds to the cAMP response element (CRE; . CREdependent gene expression is strongly induced by synaptic NMDAR activity (Hardingham and others 2002) . Ca 2+ influx through the synaptic NMDAR activates the Ras/ERK pathway in the cytoplasm and the nuclear Ca 2+ /calmodulin-dependent protein kinases, principally CaMKIV. CaMKIV mediates fast CREB phosphorylation at Ser133, whereas the ERK1/2 pathway promotes CREB phosphorylation in a slower, longer lasting manner (Hardingham and others 2001a; Wu and others 2001) . Ser133 phosphorylation of CREB is necessary to recruit CREB-binding protein (CBP), a transcriptional cofactor, to CREB. The transactivation potential of CBP is itself positively regulated by NMDAR activity (Hardingham and others 1999 ) by a mechanism involving its phosphorylation on Ser301 by CaMKIV (Impey and others 2002) . Gene expression mediated by CREB can also be mediated by another family of CREB coactivators, the transducers of regulated CREB activity (TORCs; Kovacs and others 2007; Screaton and others 2004 and references therein). TORC2 translocates to the nucleus as a result of the synergistic action of Ca 2+ and cAMP signaling through calcineurinmediated TORC2 dephosphorylation and cAMP-mediated inhibition of the TORC2 kinase SIK2, respectively (Screaton and others 2004) . In hippocampal neurons, TORC1, which is expressed more abundantly than TORC2, senses the coincidence of Ca 2+ and cAMP signaling and converges this dual signaling to target gene expression by translocating to the nucleus and potently coactivating CREB (Kovacs and others 2007) .
The potential of CREB-family-regulated gene products to promote neuronal survival was first demonstrated in the context of neurotrophin signaling (Bonni and others 1999; Riccio and others 1999) and exogenous overexpression (Walton and others 1999) . In addition, studies of mice in which CREB and/or CREB-family members have been deleted also point to a prosurvival role for CREB: CREBnull mice exhibit considerable death of dorsal-root ganglion neurons in vivo and sympathetic neurons in vitro (Lonze and others 2002) . Mice lacking CREB (and also lacking CREM, another CREB-family member) in the CNS during development show extensive neuronal apoptosis (Mantamadiotis and others 2002) . Postnatal disruption of the CREB gene (in CREM-null mice) results in progressive neurodegeneration in the hippocampus and dorsolateral striatum (Mantamadiotis and others 2002) .
CREB-dependent gene expression is causally linked to the long-lasting phase of activity-dependent neuroprotection against apoptotic insults (Papadia and others 2005) . This long-lasting phase depends on nuclear Ca 2+ /calmodulin signaling (Papadia and others 2005) , consistent with the known requirement for nuclear Ca 2+ in CREB activation via CaMKIV (Deisseroth and others 1998; Hardingham and others 2001b; Hardingham and others 1997; Limback-Stokin and others 2004) . Activity-dependent CRE activation in developing CNS neurons also protects against excitotoxic trauma (Lee and others 2005) , which would otherwise result in rapid cell death resembling necrosis. Expression of the inhibitory CREB-family member ICER increases in neurons in response to apoptotic and excitotoxic insults and can promote neuronal death (Jaworski and others 2003) . Thus, CREB activation by NMDAR signaling may be important in antagonizing the CREB-inhibiting effects of ICER accumulation.
The importance of NMDAR signaling to CREB in promoting survival in vivo is not as well established. Activation of CREB in response to transient ischemic episodes is proposed to contribute to the establishment of ischemic tolerance or preconditioning and may well be mediated by NMDAR activation (Mabuchi and others 2001) . Interestingly, resistance to hypoxic or ischemic death in different neuronal populations correlates positively with an ability to sustain active (phosphorylated) CREB (Walton and Dragunow 2000) : In neurons destined to die, CREB is only transiently phosphorylated (Walton and Dragunow 2000) .
The identity of the CRE-regulated gene or genes responsible for long-lasting protection against apoptosis is beginning to be understood. Genome-wide profiling studies have identified a large number of CREB target genes, although only a subset of these are induced by CREB-activating stimuli (Impey and others 2004; Mayr and Montminy 2001; Zhang and others 2005) . Furthermore, the identity of the genes within the subset is cell-type specific and may be stimulus-specific, so it is hard to predict in any particular scenario.
A recent study identified two genes that contribute to synaptic NMDAR-dependent neuroprotection (Zhang and others 2007) : Btg2, a potentially antiapoptotic CREB target gene, and Bc16, a transcriptional repressor implicated in suppression of p53, also potentially a CREB target. Both the Btg2 and Bc16 genes confer neuroprotection in the face of apoptotic stimuli such as trophic deprivation and staurosporine treatment, and siRNA-mediated knockdown demonstrated that their induction was also necessary for synaptic NMDAR-mediated neuroprotection.
Another CRE-regulated candidate is the prosurvival neurotrophin BDNF (brain-derived neurotrophic factor), which is up-regulated by NDMAR activity (Hardingham and others 2002) and is known to promote neuronal survival (Shieh and others 1998; Tao and others 1998; Hetman and Kharebava 2006) . NMDAR blockade in vivo reduces BDNF mRNA expression, and in vitro supplementation of neurons with BDNF can rescue them from neuronal death caused by NMDAR antagonist (Hansen and others 2004) . Up-regulation of other known CREB targets involved in metabolism and respiration (e.g., cytochrome c), responses to oxidative stress (e.g., superoxide dismutase 2 [Sod2]), or inhibition of apoptosis (e.g., Bcl-2; Riccio and others 1999) are additional potential ways in which CREB can promote survival and resistance to trauma. It is possible that different CRE-regulated genes are responsible for neuroprotection against different types of insult (e.g., apoptotic-like, excitotoxic-or necrotic-like, oxidative stress).
NMDAR-Mediated Cell Death
Pathological activation of NMDARs is a major cause of neuronal death following acute excitotoxic trauma such as brain ischemia, hypoxia, and mechanical trauma (Arundine and Tymianski 2004) . Chronic neurodegenerative diseases may also be associated with excessive NMDAR activation (Lipton 2006; Lipton and Rosenberg 1994) . Neuronal cultures respond to high levels of NMDAR activity, induced by bath application of glutamate or NMDA, by undergoing delayed Ca 2+ deregulation that precedes and predicts necrotic cell death (Hartley and others 1993 and references therein) . Several mechanisms are implicated in cell death triggered by Ca 2+ influx through the NMDAR (see below and also Fig. 1 ).
Mitochondrial dysfunction caused by excessive Ca 2+ uptake by the mitochondria through the potential-driven uniporter (Stout and others 1998) is one mechanism. The mitochondrial membrane gets depolarized because of this uptake, which inhibits ATP production and can even cause depletion of cytosolic ATP caused by reversal of the mitochondrial ATPase. This loss of ATP further limits the ability of the neuron to regulate intracellular Ca 2+ levels. Furthermore, mitochondrial Ca 2+ uptake can promote reactive oxygen species (ROS) production (Nicholls 2004 ) and the release of cytochrome c (necessary for the formation of the apoptosome and subsequent activation of caspases), leading to apoptosis.
In addition to causing mitochondrial dysfunction, toxic levels of NMDAR activation cause Ca 2+ efflux to be impaired (Bano and others 2005; Pottorf and others 2006 (Bano and others 2005) . The PMCA, which uses the energy from ATP hydrolysis to transport Ca 2+ across the plasma membrane, is inactivated by excitotoxic insults via mechanisms attributed to both caspases (Schwab and others 2002) and calpains (Pottorf and others 2006) .
NMDAR-activity-regulated overactivation of the Ca 2+ dependent nNOS also has toxic downstream responses including mitochondrial dysfunction, p38 mitogenactivated protein-kinase signaling, and activation of the transient receptor potential melastatin (TRPM) channel. nNOS is bound by its N-terminal PDZ domain to the postsynaptic-density protein PSD95, which brings it in the proximity of the synaptic NMDAR that is also bound to PSD95 via the C-terminal tail of its NR2 subunit. nNOS activation leads to nitric oxide (NO) production, which in excess can be toxic both on its own and when combined with other ROSs such as superoxide to form peroxynitrite (ONOO -). Both NO and ONOO can damage cellular components, inhibit mitochondrial respiratory-chain enzymes, and promote mitochondrial depolarization (Arundine and Tymianski 2004) . Another important target of NMDAR signaling to NO production in excitotoxicity is the cation channel TRPM7 (Aarts and others 2003) . NMDAR-dependent Ca 2+ influx triggers both NO production via nNOS activation and superoxide production via mitochondrial Ca 2+ uptake, which combine to form ONOO -, an activator of TRPM7. Because TRPM7 itself passes Ca 2+ , this results in a positive feedback loop.
Stress-activated protein kinases (SAPKs) are another class of signaling molecules that mediate NMDARdependent cell death. In CGNs, NMDAR-dependent excitotoxic death relies on p38 activation, leading to caspaseindependent cell death (Cao and others 2004) . In cortical neurons, another SAPK family, the JNKs mediate NMDAR-dependent cell death in cortical neurons in vitro and in vivo (Borsello and others 2003) . New components of the excitotoxic cell-death pathway are emerging; Rho, a member of the Rho family of GTPases, was recently found to link glutamate-induced Ca 2+ elevation to p38α-dependent excitotoxic neuronal death (Semenova and others 2007) .
What Determines If an Episode of NMDAR Activity is Neuroprotective or Excitotoxic?
As outlined above, there are a multitude of ways in which NMDAR-dependent Ca 2+ influx can convey the signal downstream either to confer neuroprotection or to trigger programs of cell death. A key issue, potentially relevant for designing clinically tolerated drugs against neurodegenerative conditions caused by excitotoxicity, is how the distinction is made as to what pathway will be followed and what factors affect this. A number of possibilities are presented here.
Stimulus Intensity
The magnitude of activation, be it intensity or duration, is very important in determining the nature of the response to an episode of NMDAR activity. The classic bell-shaped curve model of the neuronal response to NMDA or glutamate contends that intermediate, physiological NMDAR activity levels are necessary for neuroprotection, whereas pathological NMDAR activity that is too low or too high promotes cell death. This implies that the effectors of the prosurvival Ca 2+ signaling have a higher affinity (or considerably lower requirements) for Ca 2+ than the Ca 2+ effectors of death. Therefore, the Ca 2+ concentration threshold for activating prosurvival signaling by PI3K, ERK1/2, and CaMKIV must be lower than that necessary to trigger toxic levels of calpain activation, mitochondrial Ca 2+ uptake, or NO production. The key Ca 2+ -dependent components of the survival pathways are, in the main, activated not by Ca 2+ directly but by Ca 2+ /calmodulin. Calmodulin is a ubiquitous Ca 2+ -binding protein that changes conformation when it binds to Ca. Ca 2+ /calmodulin then activates a number of downstream signals, including CaMKIV and PI3K, and upstream activators of ERK1/2. As a physiological sensor of elevated Ca 2+ levels, calmodulin is designed to be activated by relatively modest increases in Ca 2+ . In contrast, central mediators of NMDAR-dependent cell death-calpains-do not depend on Ca 2+ /calmodulin but are activated by Ca 2+ directly and require higher levels to be fully induced (Tompa and others 1996) . The same can be said of the mitochondrial uniporter, which senses Ca 2+ directly and is fully activated only by high concentrations (Nicholls 2004) . Consistent with this, when increasing doses of NMDA are applied to neurons, only the higher, toxic doses evoke sustained loss of mitochondrial membrane potential and increases in mitochondrial Ca 2+ (Soriano and others 2006) . Another Ca 2+ -dependent promoter of neuronal death, nNOS, is Ca 2+ /calmodulin-dependent and indeed plays important roles in nonpathological signaling processes such as synaptic plasticity. However, nNOS is also regulated by phosphorylation, and a recent study showed that in contrast to nontoxic stimuli, high levels of glutamate fail to trigger an inhibitory phosphorylation event that ensures that nNOS activation is transient (Rameau and others 2007) . Thus, nNOS becomes excessively active and contributes to excitotoxic cell death (Rameau and others 2007) .
Location of the Receptor
Aside from stimulus intensity, the location of the NMDAR may also profoundly affect the signals that emanate from the NMDAR. Developing neurons have sizeable pools of NMDARs at extrasynaptic as well as synaptic locations, which signal very differently. Ca 2+ influx, which depends on intense synaptic NMDAR activation, is well tolerated by cells, whereas activation of extrasynaptic NMDARs, either on their own or in the presence of synaptic NMDAR activation, causes a loss of mitochondrial membrane potential and cell death (Hardingham and others 2002) .
Differential synaptic versus extrasynaptic NMDAR effects also extend to other signal pathways. Whereas synaptic NMDAR activity strongly induces CREB-dependent gene expression, extrasynaptic NMDARs are coupled to a CREB shut-off pathway that causes CREB dephosphorylation of its activator site (serine 133; Hardingham and others 2002) . The developmentally regulated mechanism of this is discussed elsewhere Sala and others 2000) . The extrasynaptic NMDAR activity-dependent dephosphorylation of CREB is generally dominant over CREB-activating signals (Hardingham and others 2002) , possibly by activating a CREB phosphatase such as protein phosphatase 1 (PP1). In neurons exposed to low protecting doses of NMDA, synaptic NMDAR signaling is able to dominate because synaptic NMDARs are preferentially activated as a result of the NMDA's causing a dramatic increase in action-potential firing (Soriano and others 2006) . This enhanced firing mediates the NMDA-induced prosurvival signaling to Akt, ERK1/2, and CREB. In contrast, higher, toxic doses of NMDA strongly suppress firing rates, and hence, do not favor synaptic NMDAR activation (Soriano and others 2006) . In addition to signaling to CREB, synaptic and extrasynaptic NMDARs in hippocampal neurons have been shown to be involved in opposing regulation of the ERK1/2 pathway: Synaptic NMDARs activate the ERK pathway, whereas extrasynaptic NMDARs evoke ERK inactivation (Ivanov and others 2006) .
A recent study involving genome-wide expression analysis has extended our understanding of synaptic versus extrasynaptic signaling (Zhang and others 2007) . Whereas synaptic NMDARs activated a number of prosurvival genes (including the aforementioned Btg2 and Bc16), extrasynaptic NMDARs failed to do this, and in fact, they activated expression of a gene, Clca1, that kills neurons. It will be of interest to know whether Clca1 is activated in vivo during excitotoxic trauma and whether it represents a potential therapeutic target.
Chronic exposure of neurons to glutamate and activation of extrasynaptic NMDARs is unlikely to occur under normal physiological conditions. However, it may occur under pathological conditions such as brain injury or during hypoxic or ischemic insults in which glutamate transporters 576 THE NEUROSCIENTIST NMDA Receptor Signaling operate in reverse (Rossi and others 2000) , thereby pumping glutamate out of the cells into the extracellular medium, where it builds up in the restricted extracellular space. Indeed, exposing hippocampal neurons to oxygenglucose-free conditions causes an NMDAR-dependent decay of CREB phosphorylation (Hardingham and others 2002) . This is consistent with the observation that CREB dephosphorylation has been observed in stroke conditions in vivo (Tanaka and others 1999; Walton and Dragunow 2000) . Given CREB's role in controlling several prosurvival genes, this shut-off may contribute to the slowly progressing apoptotic death of neurons (in response to excitotoxic trauma) exposed to toxic levels of glutamate that are insufficient to cause immediate necrotic cell death (Dirnagl and others 1999; Hossmann 1994; Lee and others 1999) . The dominant action of the shut-off signal means that any CREB-activating ligand present (such as a neurotrophin) would be rendered impotent.
The molecular basis for the apparent differences in synaptic and extrasynaptic NMDAR signaling could be attributed to differences in the composition of the NMDAR signaling complexes as opposed to the location of the receptors per se, although these potential differences await study. Molecules involved in the CREB shut-off mechanism or in the coupling to mitochondrial Ca 2+ uptake may directly interact with extrasynaptic NMDARs. They may interact less well with synaptic NMDARs because of shielding by the postsynaptic density or differences in receptor-subunit composition. Although extrasynaptic NMDARs are preferentially enriched with NR2B-containing NMDARs, there is little evidence that differences in subunit composition are dramatic enough to explain the effects observed. However, a recent study has contended that NR2B-containing NMDARs tend to promote neuronal death, irrespective of location (synaptic or extrasynaptic), whereas NR2A-containing NMDARs promote survival (Liu and others 2007) . The investigation of subunit-specific differences in NMDAR signaling is hampered by the lack of an NR2A-specific antagonist that is sufficiently selective to discriminate in the physiological scenario of transsynaptic stimulation (Frizelle and others 2006; Neyton and Paoletti 2006) . The antagonist NVP-AAM077 has some selectivity for NR2A-containing NMDARs, but the difference in the equilibrium constants is not sufficient to discriminate between NR2A-containing or NR2B-containing NMDA receptors being transsynaptically activated (Frizelle and others 2006) .
Clinical Implications and Concluding Remarks
The prosurvival role of synaptic NMDARs under physiological conditions and especially during CNS development points to the potential dangers of NMDAR antagonism during this period in humans (Olney and others 2002) . Several paediatric and obstetric anaesthetics and anticonvulsants reduce NMDAR activity directly or indirectly; in addition, in utero exposure to NMDARantagonistic recreational drugs such as phencyclidine, ketamine, and ethanol pose very real risks (Olney and others 2002) .
Moreover, the capability of NMDAR signaling to promote both survival and cell death under different circumstances highlights the problem of designing antiexcitotoxic therapeutic drugs without causing undesirable adverse effects. As outlined earlier, trials of NMDAR antagonists for treating excitotoxic trauma such as stroke have failed in the past because of poor tolerance and efficiency (Ikonomidou and Turski 2002) , likely caused by inhibition of physiological NMDAR-mediated processes such as prosurvival signaling and plasticity. It is becoming more widely accepted that the way forward is to block the excitotoxic consequences of NMDAR activation while preserving prosurvival signals, and indeed, synaptic plasticity and cognitive functioning. Thus, specifically targeting downstream proteins and pathways involved in excitotoxicity seems to be a more promising approach. Such strategies are already being developed, such as the use of cell-permeable peptides to disrupt the interaction of NR2B with PSD-95 and so uncouple NMDAR activation from nNOS activation (Aarts and others 2002) . Other promising approaches include the specific targeting of the prodeath JNK-signaling pathway, again with a cell-permeable peptide (Borsello and others 2003 ).
The precise pathway or pathways that mediate NMDAR-dependent cell death in ischemia may depend on the neuronal subtype, the severity and duration of the episode, and the position of the neuron within the lesion (infarct core or penumbra). Thus, it may be that targeting JNK signaling or NO production may ameliorate neuronal loss in some scenarios but that blocking calpain or TRPM7 activation is more effective in others. Thus, a cocktail of antideath-signaling drugs may be needed for an optimal effect. Moreover, their use, where appropriate, in conjunction with the thrombolytic drug tissue plasminogen activator (TPA) may aid in rapid drug delivery to the site of insult. In any case, the selective targeting of multiple prodeath pathways downstream of the NMDARs may represent an effective and better tolerated therapeutic strategy than simple NMDAR blockade.
